Targeted Medical Pharma, Inc. (TRGM)

Targeted Medical Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Net Income	-3.04	-3.9	-9.34	-9.59	-4.18
Depreciation & Amortization	0.23	0.4	0.41	0.44	0.46
Other Amortization	0.34	0.43	0.38	1.99	-
Loss (Gain) From Sale of Assets	0.14	-	-	-	-
Stock-Based Compensation	0.09	0.66	0.75	1.15	1.4
Provision & Write-off of Bad Debts	-	-	-	0.22	-
Other Operating Activities	-0.16	-0.01	5.51	1.25	-2.47
Change in Accounts Receivable	-0.12	0.07	0.09	0.33	-0.44
Change in Inventory	0.03	0.47	-0.12	0.02	-0.13
Change in Accounts Payable	0.4	-0.04	-0.66	1.99	3.43
Change in Income Taxes	-	0.9	-	-0.11	-0.63
Change in Other Net Operating Assets	0.8	1.8	0.94	-0.07	-0.03
Operating Cash Flow	-1.28	0.78	-2.05	-2.37	-2.59
Capital Expenditures	-	-	-0.04	-0.12	-0.08
Sale (Purchase) of Intangibles	-	-	-0.08	-0.18	-0.43
Investment in Securities	-	-	-	-	0.24
Investing Cash Flow	-	-	-0.12	-0.29	-0.27
Short-Term Debt Issued	-	-	-	3.14	0.6
Long-Term Debt Issued	1.95	0.13	3.04	-	1.6
Total Debt Issued	1.95	0.13	3.04	3.14	2.2
Short-Term Debt Repaid	-	-	-0.66	-0.29	-
Long-Term Debt Repaid	-0.6	-1.63	-0.29	-	-
Total Debt Repaid	-0.6	-1.63	-0.95	-0.29	-
Net Debt Issued (Repaid)	1.35	-1.5	2.08	2.85	2.2
Issuance of Common Stock	-	0.24	0.25	-	-
Financing Cash Flow	1.35	-1.26	2.33	2.85	2.2
Net Cash Flow	0.07	-0.48	0.17	0.18	-0.65
Free Cash Flow	-1.28	0.78	-2.08	-2.49	-2.67
Free Cash Flow Margin	-24.30%	10.97%	-21.82%	-34.11%	-30.28%
Free Cash Flow Per Share	-0.05	0.03	-0.09	-0.11	-0.12
Cash Interest Paid	0.13	0.51	0.38	-	-
Cash Income Tax Paid	-	-	-	0.1	0.63
Levered Free Cash Flow	-0.17	2.28	-1.04	0.7	-0.78
Unlevered Free Cash Flow	0.21	2.61	-1.07	0.11	-0.23
Change in Working Capital	1.11	3.2	0.25	2.16	2.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.